| 000 | 01030 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250511200235.0 | ||
| 264 | 0 | _c19910418 | |
| 008 | 199104s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/0140-6736(91)90340-u _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHart, Y M | |
| 245 | 0 | 0 |
_aFlumazenil as an anti-epileptic agent. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cMar 1991 |
||
| 300 |
_a744 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Comparative Study; Letter | ||
| 650 | 0 | 4 |
_aDiazepam _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 |
_aEpilepsy _xdrug therapy |
| 650 | 0 | 4 |
_aFlumazenil _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aSander, J W | |
| 700 | 1 | _aMeinardi, H | |
| 700 | 1 | _aNutt, D J | |
| 700 | 1 | _aShorvon, S D | |
| 773 | 0 |
_tLancet (London, England) _gvol. 337 _gno. 8743 _gp. 744 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0140-6736(91)90340-u _zAvailable from publisher's website |
| 999 |
_c1678633 _d1678633 |
||